Cerus Corporation (CERS) financial statements and ratios from SEC XBRL: revenue $233.80M (TTM), net margin -6.7%, revenue growth 16.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $233.80M |
| Net Margin | -6.7% |
| Revenue Growth (YoY) | 16.1% |
| EPS Growth (YoY) | -27.3% |
| FCF Growth (YoY) | -87.0% |
| EV / EBITDA | 361.2 |
| Price / Book | 7.95 |
| Price / Sales | 2.59 |
| FCF Yield | -3.1% |
| Altman Z-Score | -3.45 (distress) |
| Sector P/E (Healthcare) | 21.6 |
CERS overview · CERS earnings · CERS KPIs · CERS investor relations · CERS ownership · CERS peers · CERS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.